Analystreport

Health Catalyst, Inc. (NASDAQ: HCAT) had its price target raised by analysts at Citigroup Inc. from $9.00 to $10.50. They now have a "buy" rating on the stock.

Health Catalyst, Inc - Common stock  (HCAT) 
Last health catalyst, inc - common stock earnings: 2/27 04:05 pm Check Earnings Report